These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 16476713)

  • 1. Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenac.
    Alvarez-Soria MA; Largo R; Santillana J; Sánchez-Pernaute O; Calvo E; Hernández M; Egido J; Herrero-Beaumont G
    Ann Rheum Dis; 2006 Aug; 65(8):998-1005. PubMed ID: 16476713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term NSAID treatment directly decreases COX-2 and mPGES-1 production in the articular cartilage of patients with osteoarthritis.
    Alvarez-Soria MA; Herrero-Beaumont G; Moreno-Rubio J; Calvo E; Santillana J; Egido J; Largo R
    Osteoarthritis Cartilage; 2008 Dec; 16(12):1484-93. PubMed ID: 18547825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial.
    Gallelli L; Galasso O; Falcone D; Southworth S; Greco M; Ventura V; Romualdi P; Corigliano A; Terracciano R; Savino R; Gulletta E; Gasparini G; De Sarro G
    Osteoarthritis Cartilage; 2013 Sep; 21(9):1400-8. PubMed ID: 23973155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chondroprotective effect of selective COX-2 inhibition in osteoarthritis: ex vivo evaluation of human cartilage tissue after in vivo treatment.
    de Boer TN; Huisman AM; Polak AA; Niehoff AG; van Rinsum AC; Saris D; Bijlsma JW; Lafeber FJ; Mastbergen SC
    Osteoarthritis Cartilage; 2009 Apr; 17(4):482-8. PubMed ID: 18926729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synovial tissue inflammation in early and late osteoarthritis.
    Benito MJ; Veale DJ; FitzGerald O; van den Berg WB; Bresnihan B
    Ann Rheum Dis; 2005 Sep; 64(9):1263-7. PubMed ID: 15731292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsteroidal antiinflammatory drugs and prostaglandin E(2) modulate the synthesis of osteoprotegerin and RANKL in the cartilage of patients with severe knee osteoarthritis.
    Moreno-Rubio J; Herrero-Beaumont G; Tardio L; Alvarez-Soria MA; Largo R
    Arthritis Rheum; 2010 Feb; 62(2):478-88. PubMed ID: 20112374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celecoxib does not affect the release of hyaluronic acid in end stage osteoarthritic joints.
    Takahashi D; Majima T; Onodera T; Kasahara Y; Inoue M; Irie T; Kasemura T
    Mod Rheumatol; 2013 Sep; 23(5):934-8. PubMed ID: 23001685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells.
    Lev-Ari S; Strier L; Kazanov D; Elkayam O; Lichtenberg D; Caspi D; Arber N
    Rheumatology (Oxford); 2006 Feb; 45(2):171-7. PubMed ID: 16249246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
    Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro effects of aceclofenac and its metabolites on the production by chondrocytes of inflammatory mediators.
    Henrotin Y; de Leval X; Mathy-Hartet M; Mouithys-Mickalad A; Deby-Dupont G; Dogné JM; Delarge J; Reginster JY
    Inflamm Res; 2001 Aug; 50(8):391-9. PubMed ID: 11556519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nimesulide on pain and on synovial fluid concentrations of substance P, interleukin-6 and interleukin-8 in patients with knee osteoarthritis: comparison with celecoxib.
    Bianchi M; Broggini M; Balzarini P; Franchi S; Sacerdote P
    Int J Clin Pract; 2007 Aug; 61(8):1270-7. PubMed ID: 17590218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analgesic effectiveness of celecoxib and diclofenac in patients with osteoarthritis of the hip requiring joint replacement surgery: a 12-week, multicenter, randomized, double-blind, parallel-group, double-dummy, noninferiority study.
    Emery P; Koncz T; Pan S; Lowry S
    Clin Ther; 2008 Jan; 30(1):70-83. PubMed ID: 18343244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib.
    Tannenbaum H; Berenbaum F; Reginster JY; Zacher J; Robinson J; Poor G; Bliddal H; Uebelhart D; Adami S; Navarro F; Lee A; Moore A; Gimona A
    Ann Rheum Dis; 2004 Nov; 63(11):1419-26. PubMed ID: 15020310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee: a 13-week, randomized, double-blind comparison with celecoxib and placebo.
    Sheldon E; Beaulieu A; Paster Z; Dutta D; Yu S; Sloan VS
    Clin Ther; 2005 Jan; 27(1):64-77. PubMed ID: 15763607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participation of cyclooxygenase-1 in prostaglandin E2 release from synovitis tissue in primary osteoarthritis in vitro.
    Knorth H; Dorfmüller P; Lebert R; Schmidt WE; Wittenberg RH; Heukamp M; Wiese M; Willburger RE
    Osteoarthritis Cartilage; 2004 Aug; 12(8):658-66. PubMed ID: 15262246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants.
    Hardy MM; Seibert K; Manning PT; Currie MG; Woerner BM; Edwards D; Koki A; Tripp CS
    Arthritis Rheum; 2002 Jul; 46(7):1789-803. PubMed ID: 12124863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nonsteroidal anti-inflammatory drugs on the expression of urokinase plasminogen activator and inhibitor and gelatinases in the early osteoarthritic knee of humans.
    Yang SF; Hsieh YS; Lue KH; Chu SC; Chang IC; Lu KH
    Clin Biochem; 2008 Jan; 41(1-2):109-16. PubMed ID: 17996201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cyclooxygenase 2 expression by diallyl sulfide on joint inflammation induced by urate crystal and IL-1beta.
    Lee HS; Lee CH; Tsai HC; Salter DM
    Osteoarthritis Cartilage; 2009 Jan; 17(1):91-9. PubMed ID: 18573668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of COX-2 by celecoxib in the canine groove model of osteoarthritis.
    Mastbergen SC; Marijnissen AC; Vianen ME; Zoer B; van Roermund PM; Bijlsma JW; Lafeber FP
    Rheumatology (Oxford); 2006 Apr; 45(4):405-13. PubMed ID: 16287921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 is an enhancer of interleukin-1beta-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts.
    Kojima F; Naraba H; Sasaki Y; Beppu M; Aoki H; Kawai S
    Arthritis Rheum; 2003 Oct; 48(10):2819-28. PubMed ID: 14558087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.